ARCHIVES

IOM Report Lists Cancer CER Priorities

This article is from The Cancer Letter archive.

Vol. 35 No. 26 | July 3, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

NCI-Approved Clinical Trials

December 31, 2004

NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements

December 5, 2014

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

Counseling reduces Pain, Study Shows

April 18, 1986